223 related articles for article (PubMed ID: 29046987)
1. Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease.
Qureshi S; Lorch R; Navaneethan SD
Curr Hypertens Rep; 2017 Oct; 19(11):92. PubMed ID: 29046987
[TBL] [Abstract][Full Text] [Related]
2. Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies.
Gosmanova EO; Kovesdy CP
Curr Cardiol Rep; 2016 Sep; 18(9):88. PubMed ID: 27448402
[TBL] [Abstract][Full Text] [Related]
3. Hypertension in chronic kidney disease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties.
Kovesdy CP
Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii219-ii223. PubMed ID: 28201651
[TBL] [Abstract][Full Text] [Related]
4. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.
Malhotra R; Nguyen HA; Benavente O; Mete M; Howard BV; Mant J; Odden MC; Peralta CA; Cheung AK; Nadkarni GN; Coleman RL; Holman RR; Zanchetti A; Peters R; Beckett N; Staessen JA; Ix JH
JAMA Intern Med; 2017 Oct; 177(10):1498-1505. PubMed ID: 28873137
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease.
Walther CP; Chandra A; Navaneethan SD
Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):16-22. PubMed ID: 29045334
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Hypertension: Which Goal for Which Patient?
Jarraya F
Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
[TBL] [Abstract][Full Text] [Related]
7. Systolic blood pressure and outcomes in stage 3-4 chronic kidney disease patients: evidence from a Taiwanese cohort.
Chiang HP; Lee JJ; Chiu YW; Tsai JC; Hung CC; Hwang SJ; Chen HC
Am J Hypertens; 2014 Nov; 27(11):1396-407. PubMed ID: 24727359
[TBL] [Abstract][Full Text] [Related]
8. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
[TBL] [Abstract][Full Text] [Related]
9. Nighttime Systolic Blood-Pressure Load Is Correlated with Target-Organ Damage Independent of Ambulatory Blood-Pressure Level in Patients with Non-Diabetic Chronic Kidney Disease.
Wang C; Zhang J; Deng W; Gong W; Liu X; Ye Z; Peng H; Lou T
PLoS One; 2015; 10(7):e0131546. PubMed ID: 26186336
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.
Navaneethan SD; Schold JD; Jolly SE; Arrigain S; Blum MF; Winkelmayer WC; Nally JV
Kidney Int; 2017 Nov; 92(5):1272-1281. PubMed ID: 28750929
[TBL] [Abstract][Full Text] [Related]
11. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
Aggarwal R; Petrie B; Bala W; Chiu N
Hypertension; 2019 Jun; 73(6):1275-1282. PubMed ID: 31067189
[TBL] [Abstract][Full Text] [Related]
12. Blood Pressure Goals in Patients with CKD: A Review of Evidence and Guidelines.
Chang AR; Lóser M; Malhotra R; Appel LJ
Clin J Am Soc Nephrol; 2019 Jan; 14(1):161-169. PubMed ID: 30455322
[TBL] [Abstract][Full Text] [Related]
13. [Limitations of blood pressure target in non-dialysis chronic kidney disease: a question of method?].
Borrelli S; De Nicola L; Minutolo R; Sagliocca A; Garofalo C; Liberti ME; Pacilio M; Iorio V; Michini C; Pirro L; Conte G
G Ital Nefrol; 2012; 29(4):418-24. PubMed ID: 22843154
[TBL] [Abstract][Full Text] [Related]
14. Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?
Dasgupta I; Zoccali C
Hypertension; 2022 Jan; 79(1):4-11. PubMed ID: 34784720
[TBL] [Abstract][Full Text] [Related]
15. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
Bhatt H; Ghazi L; Calhoun D; Oparil S
Curr Cardiol Rep; 2016 Oct; 18(10):98. PubMed ID: 27566331
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure control in patients with chronic kidney disease.
Lee JY; Han SH
Korean J Intern Med; 2021 Jul; 36(4):780-794. PubMed ID: 34153181
[TBL] [Abstract][Full Text] [Related]
17. Hypertension Management in Patients with Chronic Kidney Disease in the Post-SPRINT Era.
Jung HH
Electrolyte Blood Press; 2021 Dec; 19(2):19-28. PubMed ID: 35003282
[TBL] [Abstract][Full Text] [Related]
18. Applying the new intensive blood pressure categories to a nondialysis chronic kidney disease population: the Prevalence, Awareness and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China survey.
Zheng Y; Tang L; Zhang W; Zhao D; Zhang D; Zhang L; Cai G; Chen X;
Nephrol Dial Transplant; 2020 Jan; 35(1):155-161. PubMed ID: 30304540
[TBL] [Abstract][Full Text] [Related]
19. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
[TBL] [Abstract][Full Text] [Related]
20. Relationship between blood pressure and kidney diseases in large randomized controlled trials: secondary analyses using SPRINT and ACCORD-BP trials.
Wang L; Pezeshkian K; Rayamajhi S; Herzallah K; Al-Abcha A; Olomu A; Kelly-Blake K; Yu E; Wang DH
J Hum Hypertens; 2021 Oct; 35(10):859-869. PubMed ID: 33093616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
